{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:59:19Z","timestamp":1789016359144,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T00:00:00Z","timestamp":1492992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T00:00:00Z","timestamp":1492992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1038\/bmt.2017.59","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T14:23:26Z","timestamp":1493043806000},"page":"1512-1518","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["A review of hematopoietic cell transplantation in China: data and trends during 2008\u20132016"],"prefix":"10.1038","volume":"52","author":[{"given":"L-P","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D-P","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-Z","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q-F","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D-H","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z-M","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L-H","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-X","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-F","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-R","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-M","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D-B","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-P","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K-Y","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X-J","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Chinese Blood and Marrow Transplantation Register Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,24]]},"reference":[{"key":"BFbmt201759_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/bmt.2016.18","volume":"51","author":"D Niederwieser","year":"2016","unstructured":"Niederwieser D, Baldomero H, Szer J, Gratwohl M, Aljurf M, Atsuta Y et al. Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. Bone Marrow Transplant 2016; 51: 778\u2013785.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201759_CR2","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/bmt.2016.20","volume":"51","author":"JR Passweg","year":"2016","unstructured":"Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P et al. Hematopoietic stem cell transplantation in Europe 2014: more than 40000 transplants annually. Bone Marrow Transplant 2016; 51: 786\u2013792.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201759_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/bmt.2014.312","volume":"50","author":"JR Passweg","year":"2015","unstructured":"Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P et al. Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants. Bone Marrow Transplant 2015; 50: 476\u2013482.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201759_CR4","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1038\/bmt.2010.34","volume":"45","author":"A Yoshimi","year":"2010","unstructured":"Yoshimi A, Suzuki R, Atsuta Y, Iida M, Lu DP, Tong W et al. Hematopoietic SCT activity in Asia: a report from the Asia-Pacific Blood and Marrow Transplantation Group. Bone Marrow Transplant 2010; 45: 1682\u20131691.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201759_CR5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/petr.12525","volume":"19","author":"H Du","year":"2015","unstructured":"Du H, Chen J, Qin M, Fang J, Li Z, Zhu Y et al. Pediatric hematopoietic stem cell transplantation in China: data and trends during 1998\u20132012. Pediatr Transplant 2015; 19: 563\u2013570.","journal-title":"Pediatr Transplant"},{"key":"BFbmt201759_CR6","unstructured":"Stem cell application group of Hematology branch of Chinese Association. Consensus on allogeneic hematopoietic stem cell transplantation in China: indication and condition regimen and donors. Chinese J Hematol 2014; 35: 775\u2013778."},{"key":"BFbmt201759_CR7","unstructured":"National Comprehensive Cancer Network. NCCN Guidelines for Treatment of Cancer by Site: Acute Myeloid Leukemia. NCCN: Fort Washington, PA, USA, 2016. https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp#site"},{"key":"BFbmt201759_CR8","unstructured":"National Comprehensive Cancer Network. NCCN Guidelines for Treatment of Cancer by Site: Acute Lymphoblastic Leukemia. NCCN: Fort Washington, PA, USA, 2016. https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp#site"},{"key":"BFbmt201759_CR9","unstructured":"National Comprehensive Cancer Network. NCCN Guidelines for Treatment of Cancer by Site: Chronic Myeloid Leukemia. NCCN: Fort Washington, PA, USA, 2016. https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp#site"},{"key":"BFbmt201759_CR10","unstructured":"National Comprehensive Cancer Network. NCCN Guidelines for Treatment of Cancer by Site: Myelodysplastic Syndromes. NCCN: Fort Washington, PA, USA, 2016. https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp#site"},{"key":"BFbmt201759_CR11","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/cncr.27761","volume":"119","author":"Y Wang","year":"2013","unstructured":"Wang Y, Liu DH, Liu KY, Xu LP, Zhang XH, Han W et al. Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center. Cancer 2013; 119: 978\u2013985.","journal-title":"Cancer"},{"key":"BFbmt201759_CR12","doi-asserted-by":"publisher","first-page":"5584","DOI":"10.1182\/blood-2011-11-389809","volume":"119","author":"XJ Huang","year":"2012","unstructured":"Huang XJ, Zhu HH, Chang YJ, Xu LP, Liu DH, Zhang XH et al. The superiority of haploidentical related stem cell transplantation to chemotherapy alone as post-remission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission. Blood 2012; 119: 5584\u20135590.","journal-title":"Blood"},{"key":"BFbmt201759_CR13","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1182\/blood-2012-11-468348","volume":"121","author":"HH Zhu","year":"2013","unstructured":"Zhu HH, Zhang XH, Qin YZ, Liu DH, Jiang H, Chen H et al. MRD-directed risk stratification treatment may improve outcomes of t (8;21) AML in the first complete remission: results from the AML05 multicenter trial. Blood 2013; 121: 4056\u20134062.","journal-title":"Blood"},{"key":"BFbmt201759_CR14","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.3109\/10428194.2015.1032964","volume":"56","author":"YZ Qin","year":"2015","unstructured":"Qin YZ, Xu LP, Chen H, Jiang Q, Wang Y, Jiang H et al. Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy. Leuk Lymphoma 2015; 56: 3116\u20133123.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt201759_CR15","first-page":"721","volume":"37","author":"Y Wang","year":"2016","unstructured":"Wang Y, Huang XJ . Haploidentical transplantation for the treatment of intermediate- or high-risk acute myeloid leukemia in first complete remission: guideline and practice. Chinese J Hematol 2016; 37: 721\u2013724.","journal-title":"Chinese J Hematol"},{"key":"BFbmt201759_CR16","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.bbmt.2014.04.011","volume":"20","author":"CH Yan","year":"2014","unstructured":"Yan CH, Jiang Q, Wang J, Xu LP, Liu DH, Jiang H et al. Superior survival of unmanipulated haploidentical HSCT compared with chemotherapy alone used as post-remission therapy in adult standard-risk acute lymphoblastic leukemia in first complete remission. Biol Blood Marrow Transplant 2014; 20: 1314\u20131321.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201759_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/bmt.2014.195","volume":"50","author":"YQ Sun","year":"2015","unstructured":"Sun YQ, Wang J, Jiang Q, Xu LP, Liu DH, Zhang XH et al. Haploidentical hematopoietic SCT may be superior to conventional consolidation\/maintenance chemotherapy as post-remission therapy for high-risk adult ALL. Bone Marrow Transplant 2015; 50: 20\u201325.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201759_CR18","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1158\/1078-0432.CCR-15-2335","volume":"22","author":"Y Wang","year":"2016","unstructured":"Wang Y, Liu QF, Xu LP, Liu KY, Zhang XH, Ma X et al. Haploidentical versus matched-sibling transplant in adults with Philadelphia-negative high-risk acute lymphoblastic leukemia: a Biologically Phase III Randomized Study. Clin Cancer Res 2016; 22: 3467\u20133476.","journal-title":"Clin Cancer Res"},{"key":"BFbmt201759_CR19","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.bbmt.2011.08.024","volume":"18","author":"Y Wang","year":"2012","unstructured":"Wang Y, Liu DH, Xu LP, Liu KY, Chen H, Chen YH et al. Haploidentical\/mismatched hematopoietic stem cell transplantation without in vitro T cell depletion for T cell acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2012; 18: 716\u2013721.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201759_CR20","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/petr.12704","volume":"20","author":"ZL Xu","year":"2016","unstructured":"Xu ZL, Huang XJ, Liu KY, Chen H, Zhang XH, Han W et al. Haploidentical hematopoietic stem cell transplantation for paediatric high-risk T-cell acute lymphoblastic leukaemia. Pediatr Transplant 2016; 20: 572\u2013580.","journal-title":"Pediatr Transplant"},{"key":"BFbmt201759_CR21","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.bbmt.2015.02.009","volume":"21","author":"H Chen","year":"2015","unstructured":"Chen H, Liu KY, Xu LP, Chen YH, Han W, Zhang XH et al. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2015; 21: 1110\u20131116.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201759_CR22","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1182\/blood-2010-09-308510","volume":"117","author":"Q Jiang","year":"2011","unstructured":"Jiang Q, Xu LP, Liu DH, Liu KY, Chen SS, Jiang B et al. Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase. Blood 2011; 117: 3032\u20133040.","journal-title":"Blood"},{"key":"BFbmt201759_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s11684-015-0400-4","volume":"9","author":"L Xu","year":"2015","unstructured":"Xu L, Zhu H, Hu J, Wu D, Jiang H, Jiang Q et al. Superiority of allogeneic hematopoietic stem cell transplantation to nilotinib and dasatinib for adult patients with chronic myelogenous leukemia in the accelerated phase. Front Med 2015; 9: 304\u2013311.","journal-title":"Front Med"},{"key":"BFbmt201759_CR24","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/bmt.2014.146","volume":"49","author":"H Jiang","year":"2014","unstructured":"Jiang H, Xu LP, Liu DH, Liu KY, Chen SS, Jiang B et al. Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisis. Bone Marrow Transplant 2014; 49: 1146\u20131154.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201759_CR25","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.bbmt.2016.03.012","volume":"22","author":"LP Xu","year":"2016","unstructured":"Xu LP, Xu ZL, Zhang XH, Chen H, Chen YH, Han W et al. Allogeneic stem cell transplantation for patients with T315I BCR-ABL mutated chronic myeloid leukemia. Biol Blood Marrow Transplant 2016; 22: 1080\u20131086.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201759_CR26","first-page":"513","volume":"91","author":"A Gratwohl","year":"2006","unstructured":"Gratwohl A, Brand R, Apperley J, Crawley C, Ruutu T, Corradini P et al. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2006; 91: 513\u2013521.","journal-title":"Haematologica"},{"key":"BFbmt201759_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/bjh.14225","volume":"175","author":"LP Xu","year":"2016","unstructured":"Xu LP, Wang SQ, Wu DP, Wang JM, Gao SJ, Jiang M et al. Haplo-identical transplantation for acquired severe aplastic anemia in a multi-center prospective study. Br J Haematol 2016; 175: 265\u2013274.","journal-title":"Br J Haematol"},{"key":"BFbmt201759_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-017-0398-y","volume":"10","author":"LP Xu","year":"2017","unstructured":"Xu LP, Jin S, Wang SQ, Xia LH, Bai H, Gao SJ et al. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant. J Hematol Oncol 2017; 10: 25.","journal-title":"J Hematol Oncol"},{"key":"BFbmt201759_CR29","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1182\/blood-2014-03-563130","volume":"124","author":"Y Wang","year":"2014","unstructured":"Wang Y, Chang YJ, Xu LP, Liu KY, Liu DH, Zhang XH et al. Who is the best donor for a related HLA-haplotype-mismatched transplant? Blood 2014; 124: 843\u2013850.","journal-title":"Blood"},{"key":"BFbmt201759_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-015-0182-9","volume":"8","author":"YJ Chang","year":"2015","unstructured":"Chang YJ, Zhao XY, Xu LP, Zhang XH, Wang Y, Han W et al. Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets. J Hematol Oncol 2015; 8: 84\u201392.","journal-title":"J Hematol Oncol"},{"key":"BFbmt201759_CR31","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1182\/blood-2015-02-627786","volume":"125","author":"Y Wang","year":"2015","unstructured":"Wang Y, Liu QF, Xu LP, Liu KY, Zhang XH, Ma X et al. Haploidentical vs. identical-sibling transplant for AML in remission: a multicenter, prospective study. Blood 2015; 125: 3956\u20133962.","journal-title":"Blood"},{"key":"BFbmt201759_CR32","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1038\/leu.2016.110","volume":"30","author":"Y Wang","year":"2016","unstructured":"Wang Y, Wang HX, Lai YR, Sun ZM, Wu DP, Jiang M et al. Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant. Leukemia 2016; 30: 2055\u20132063.","journal-title":"Leukemia"},{"key":"BFbmt201759_CR33","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/bmt.2013.99","volume":"48","author":"DH Liu","year":"2013","unstructured":"Liu DH, Xu LP, Liu KY, Wang Y, Chen H, Han W et al. Long-term outcomes of unmanipulated haploidentical HSCT for paediatric patients with acute leukaemia. Bone Marrow Transplant 2013; 48: 1519\u20131524.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201759_CR34","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/ctr.12779","volume":"30","author":"YR Ma","year":"2016","unstructured":"Ma YR, Huang XJ, Xu ZL, Liu KY, Chen H, Zhang XH et al. Transplantation from haploidentical donor is not inferior to that from identical sibling donor for patients with chronic myeloid leukemia in blast crisis or chronic phase from blast crisis. Clin Transplant 2016; 30: 994\u20131001.","journal-title":"Clin Transplant"},{"key":"BFbmt201759_CR35","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.3324\/haematol.2015.140509","volume":"101","author":"Y Sun","year":"2016","unstructured":"Sun Y, Beohou E, Labopin M, Volin L, Milpied N, Yakoub-Agha I et al. Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT database. Acute Leukemia Working Party of the EBMT. Haematologica 2016; 101: e352\u2013e354.","journal-title":"Haematologica"},{"key":"BFbmt201759_CR36","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1158\/1078-0432.CCR-09-0691","volume":"15","author":"XJ Huang","year":"2009","unstructured":"Huang XJ, Xu LP, Liu KY, Liu DH, Wang Y, Chen H et al. Partially matched related donor transplantation can achieve outcomes comparable with unrelated donor transplantation for patients with hematologic malignancies. Clin Cancer Res 2009; 15: 4777\u20134783.","journal-title":"Clin Cancer Res"},{"key":"BFbmt201759_CR37","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1002\/ijc.30249","volume":"139","author":"XD Mo","year":"2016","unstructured":"Mo XD, Tang BL, Zhang XH, Zheng CC, Xu LP, Zhu XY et al. Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemia. Int J Cancer 2016; 139: 2106\u20132115.","journal-title":"Int J Cancer"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt201759.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201759","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bmt.2017.59","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201759.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T20:06:15Z","timestamp":1648065975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt201759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,24]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["BFbmt201759"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2017.59","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,24]]},"assertion":[{"value":"27 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}